Uses, Side Effects, Price of Tacrograf 0.25mg Capsule 10'S:

Tacrograf 0.25 Capsule is used in conjunction with other medications to keep your body from rejecting a new organ (such as a liver, kidney, or heart) after a transplant. It accomplishes this by weakening your immune system so that it does not attack the new organ. This medication belongs to the immunosuppressant class of drugs.

The amount of Tacrograf 0.25 Capsule you take and how often you take it depends on the type of transplant you have, your body weight, and what other medicines you are taking. Follow your doctor’s instructions carefully. You should take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Take this medicine regularly to get the maximum benefit and keep taking it, even if you feel well. If you stop taking it, you may increase the chances of rejecting your transplanted organ.

Tacrograf 0.25 Capsule may cause a variety of side effects. It has the potential to cause or worsen diabetes, and kidney and liver problems. These people require immediate medical attention. Nausea, stomach pain, diarrhea, and difficulty sleeping are also common side effects. Inform your doctor if the side effects persist or worsen. Tacrograf 0.25 Capsule suppresses your immune system, making you more susceptible to infections than usual.

Inform your doctor if you have kidney, liver, or heart disease, diabetes, or high blood pressure before taking this medication. Inform your doctor about any other medications you are taking, particularly those for infections, pain, and arthritis. These and other factors may influence or be influenced by this medication. Because immunosuppressants may increase your risk of skin cancer, you should limit your exposure to the sun and UV (ultraviolet) light while taking it.

USES OF Tacrograf 0.25mg Capsule 10'S

• Organ rejection prevention in transplant recipients

Benefits of Tacrograf 0.25mg Capsule 10'S:

In Prevention of organ rejection in transplant patients

Tacrograf 0.25 Capsule is a type of medicine known as an immunosuppressant. When your immune system perceives the new organ as an invader and attacks it, this is referred to as organ rejection. This medication reduces the likelihood of your body attacking the transplanted organ by weakening your immune response (which normally fights infection). It is used in conjunction with other medications to increase the likelihood that your transplant will be successful. You should keep taking the medication until your doctor tells you to stop.

SIDE EFFECTS OF Tacrograf 0.25mg Capsule 10'S:

Most side effects are harmless and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.

• Diarrhea
• Increased thirst due to an increase in blood glucose levels
• Kidney disease
• Damage to the liver
• Nausea
• stomach ache

Caution :

• Keep out of reach of children.
• Keep away from direct sunlight.

FAQs:

Q1 Is Tacrograf 0.25 Capsule an antibiotic? Yes, Tacrograf 0.25 Capsule is an antibiotic that belongs to the macrolide class of medications. It is primarily used following organ transplantation. The immunosuppressive property of this medication aids in the prevention of organ rejection following a kidney, heart, or liver transplant.

Q2 Which vaccines should not be taken while taking Tacrograf 0.25 Capsule? While taking Tacrograf 0.25 Capsule, you should avoid taking any live vaccines (vaccines that use pathogens that are still alive but have been attenuated, or weakened). Vaccinations for measles, mumps, rubella, BCG (TB vaccine), yellow fever, chicken pox, and typhoid may be included. You should also avoid using polio drops or flu vaccine (through nose).

Q3. What should I tell my doctor before taking Tacrograf 0.25 Capsule? If you are pregnant, have allergies, a long-term infection, high blood sugar, or high blood pressure, tell your doctor. If you have high blood potassium levels or a weakened immune system, you should also notify your doctor. Inform your doctor if you have a medication history or if you have recently received or are scheduled to receive a live vaccine.